(Q42683780)

English

OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials

scientific article published on 28 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

0 references

OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials (English)

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

0 references

author name string

R L Manno

1

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

C O Bingham

2

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

S Paternotte

3

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

L Gossec

4

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

H Halhol

5

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

G Giacovelli

6

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

L Rovati

7

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

S A Mazzuca

8

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

D O Clegg

9

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

H Shi

10

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

E Tajana Messi

11

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

A Lanzarotti

12

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

M Dougados

13

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 November 2011

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

Osteoarthritis and Cartilage

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

20

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

93-101

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacemen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

A prospective population-based study of the predictors of undergoing total joint arthroplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

International variation in hip replacement rates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

27 May 2018

Comparative evaluation of three semi-quantitative radiographic grading techniques for hip osteoarthritis in terms of validity and reproducibility in 1404 radiographs: report of the OARSI-OMERACT Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

16 August 2018

Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

16 August 2018

Disability and quality of life of patients with knee or hip osteoarthritis in the primary care setting and factors associated with general practitioners' indication for prosthetic replacement within 1 year.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

16 August 2018

Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4375956

16 August 2018

Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The OMERACT filter for Outcome Measures in Rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22178465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JOCA.2011.11.013

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42683780&oldid=1625743992"